HomePHAR • NASDAQ
Follow
Pharming Group N V ADS each representing 10 Ord Shs
Market news
.INX
0.11%
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 81.20M | 48.66% |
Operating expense | 73.00M | 9.95% |
Net income | -2.70M | 81.54% |
Net profit margin | -3.33 | 87.57% |
Earnings per share | -0.00 | 80.95% |
EBITDA | 8.66M | 178.17% |
Effective tax rate | -35.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 213.20M | 2.83% |
Total assets | 461.42M | 8.37% |
Total liabilities | 242.24M | 9.53% |
Total equity | 219.19M | — |
Shares outstanding | 675.00M | — |
Price to book | 33.91 | — |
Return on assets | 0.61% | — |
Return on capital | 0.72% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.70M | 81.54% |
Cash from operations | 11.36M | 116.91% |
Cash from investing | -3.91M | -879.45% |
Cash from financing | -1.02M | -466.91% |
Net change in cash | 6.87M | -63.16% |
Free cash flow | 4.46M | 244.79% |
About
Founded
1988
Website
Employees
332